RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.
about
Mitochondrial cytochrome c oxidase deficiencyPioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammationPhenotypic rescue of a Drosophila model of mitochondrial ANT1 disease.Treatment of mitochondrial disorders.Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.Potential compounds for the treatment of mitochondrial disease.Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndromeMitochondrial dysfunction in central nervous system white matter disorders.PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo.Therapies for mitochondrial diseases and current clinical trials.The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.Understanding mitochondrial myopathies: a review.
P2860
Q26769015-68F800DA-B64C-48EA-8C7C-7AFCB5C1442EQ27301100-54B3A4B4-7C86-49B2-B1FC-B1CD218F466EQ30579069-B2C7BAC4-302A-4B95-A0C4-9C22BA7FE62BQ33794684-8F971A30-167F-4A8D-968D-6C7FB7747FD4Q34287719-267D27DA-1915-44F2-9A32-853427CE0BB9Q35234097-079E61BB-853D-4E8A-81F3-0FA120177F9EQ35847813-BBDBC983-AF18-4982-BDE0-F5C1305C8CECQ35893619-001B1F55-967B-4CD2-B226-18A99449DE44Q37368003-5ADFDF90-A705-43E3-B1E7-E16D32B93CF9Q37686240-3D69A74A-C0DC-41B3-B432-5EE25DA73F7BQ37692607-233B76EC-168A-4138-AD4C-F787C85EF7D7Q38215315-F463BFAC-8114-44BC-ABAC-E076D0D8CD73Q39145017-D22FF560-394E-47B8-BB1C-4DC9D22871E7Q39295659-2C4E0774-EE8A-438A-9F31-1F0D6DA1CAC6Q45872396-FAFB779E-572F-4A3B-AEDD-207C0E4EAF2DQ47845826-56B46513-B2E3-40E2-902B-C7C41504EF62Q52562680-A7E0FDAB-6DB5-4BFF-AD45-1FC320C85063Q55066238-611DA4E7-191A-4D28-ACDC-84C04E64D1F7
P2860
RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
RETRACTED: Bezafibrate improve ...... mitochondrial encephalopathy.
@en
type
label
RETRACTED: Bezafibrate improve ...... mitochondrial encephalopathy.
@en
prefLabel
RETRACTED: Bezafibrate improve ...... mitochondrial encephalopathy.
@en
P2093
P2860
P1433
P1476
RETRACTED: Bezafibrate improve ...... mitochondrial encephalopathy.
@en
P2093
Aline Hida
Carlos T Moraes
Francisca Diaz
Lloye Dillon
Natalie Noe
Veronika Lellek
P2860
P304
P356
10.1016/J.MITO.2012.12.003
P577
2012-12-20T00:00:00Z